Rapid Micro Biosystems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lean management has become standard for manufacturers worldwide, and companies in almost every industry are stripping waste with new technologies and more efficient production processes. While pharmaceutical manufacturers have followed suit in the production of their products, they’ve been slow to embrace lean initiatives in quality control (QC) – until now.


Over the last decade, forward-thinking drug companies have adopted a variety of rapid microbiological method (RMM) technologies, complementing – and in some cases, replacing – the century-old manual method of incubating and counting colonies for microbial testing.
Compared to traditional and alternative techniques, the Growth Direct(TM) System's benefits include:
·         Automation of error prone tasks
·         Non-destructive results
·         A simple validation process
·         Network integration
·         Rapid results
Through the creation of leaner, more efficient QC labs, these benefits have allowed several major pharmaceutical companies to increase their efficiency. Download your free copy to hear their stories!

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FindPharma Custom Search

Click here